Trial Profile
Phase I Trial of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Mar 2024
Price :
$35
*
At a glance
- Drugs INO 8000 (Primary) ; INO 9012 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics
- 05 Mar 2024 Planned End Date changed from 14 Feb 2020 to 4 Mar 2025.
- 04 Feb 2020 Planned primary completion date changed from 31 Jan 2020 to 14 Feb 2020.
- 04 Feb 2020 Status changed from recruiting to active, no longer recruiting.